Expression of Bcl-2 and c-Myc oncogenes and P53 and P16 anti-oncogenes in early development-arrest-embryo tissue
DOI:
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To explore the differential expression of oncogenes and anti-oncogenes in early development-arrest-embryo tissue and normal early embryonic tissue. Methods:The expression of Bcl-2 and c-Myc oncogenes and P53 and P16 anti-oncogenes in chorionic tissue were analyzed by immunohistochemical method from 56 cases of normal early embryonic tissue and 68 cases of early development-arrest-embryo tissue. Results:The positive rates of Bcl-2 and c-Myc oncogenes in normal early embryonic tissue and early development-arrest-embryo tissue were 53.57%(30/56) vs. 30.36%(17/56) and 77.94%(53/68) vs. 45.59%(31/68) respectively. The positive rates of P53 and P16 anti-oncogenes in normal early embryonic tissue and early development-arrest-embryo tissue were 39.29%(22/56) vs. 73.21%(41/56) and 27.94%(19/68) vs. 47.06%(32/68) respectively. Conclusion:The balanced expression of oncogenes and anti-oncogenes plays an important role in early embryonic development.

    Reference
    Related
    Cited by
Get Citation

Xie Yuanzhi, Wang Zhengyao, Cai Jingjing, Cao Hui, Chen Jing, Wu Jinxiang. Expression of Bcl-2 and c-Myc oncogenes and P53 and P16 anti-oncogenes in early development-arrest-embryo tissue[J]. Journal of Chongqing Medical University,2022,47(2):135-139

Copy
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:
  • Revised:
  • Adopted:
  • Online: April 15,2022
  • Published:
Article QR Code